证券代码：603883 证券简称：老百姓 公告编号：2025-064 老百姓大药房连锁股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2025年第一次临时股东大会 召开的日期时间：2025 年 11 月 28 日15 点 30 分 召开地点：湖南省长沙市开福区青竹湖路 808 号老百姓 15 楼会议室 (五) 网络投票的系统、起止日期和投票时间 股东大会召开日期：2025年11月28日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关 ...

Core Viewpoint - On October 28, the company released its Q3 2025 earnings report, achieving revenue of 16.07 billion yuan, a year-on-year decrease of 1.0%, and a net profit attributable to shareholders of 529 million yuan, down 16.07% year-on-year. The basic earnings per share were 0.70 yuan, aligning with previous expectations. Looking ahead to Q4 2025 and 2026, the company is fully initiating a "dual-line" transformation, optimizing store layouts, enhancing procurement efficiency, and strengthening digital management to improve operational efficiency [1][2][3] Financial Performance - For the first three quarters of 2025, the company reported a revenue decline of 1.0% year-on-year, with a net profit drop of 16.07% and a non-recurring net profit decrease of 18.55%. In Q3 2025, revenue was 5.296 billion yuan, showing a slight year-on-year improvement in net profit by 2.62% [2][3] - The company plans to distribute a cash dividend of 0.14 yuan per share (before tax), totaling 106 million yuan, which accounts for 20.10% of the net profit attributable to shareholders for the first three quarters of 2025 [2] Operational Improvements - The company added 756 new stores in the first three quarters of 2025, with a net increase of 215 stores, bringing the total to 15,492. The focus remains on enhancing market presence in advantageous regions and lower-tier cities, with 90.5% of stores located in key provinces and cities [4] - The company is undergoing a "dual-line" transformation, shifting from a "transaction-based" to a "relationship-based" store model, enhancing service quality and employee training [5][6] Supply Chain and AI Integration - The company is improving procurement efficiency, with centralized procurement increasing by 3.9 percentage points to 75.2%. The self-owned brand sales ratio in self-operated stores rose by 0.9 percentage points to 22.8% [7] - AI capabilities are being strengthened across various dimensions, including technology, application scenarios, and talent development, which is expected to enhance operational efficiency and contribute to revenue growth [7] Market Strategy and Customer Engagement - The company is focusing on specialized services for chronic and severe diseases, with over 21.61 million patients registered in chronic disease management services and a total membership of 106.31 million [8] - The company is also expanding its health service offerings, integrating product, service, and scenario strategies to build a competitive edge in the market [8] Future Outlook - Looking ahead to Q4 2025 and 2026, the company is expected to continue optimizing store layouts and enhancing market share, which should lead to increased customer traffic and revenue growth. The ongoing improvements in procurement and self-owned brand ratios are anticipated to further enhance gross margins [9][10] - The company forecasts revenues of 22.71 billion yuan, 24.55 billion yuan, and 26.99 billion yuan for 2025 to 2027, with corresponding net profits of 649 million yuan, 747 million yuan, and 860 million yuan, indicating a positive growth trajectory [11]

Core Viewpoint - The construction boom of data centers in the U.S. is facing scrutiny from politicians due to its significant pressure on the power grid and direct impact on consumer electricity prices, raising concerns about inflation and regulatory risks for tech companies [1][3]. Group 1: Political Response - A group of left-leaning senators, led by Senator Sanders, has urged the U.S. government to explain how it will address rising electricity prices exacerbated by data center expansion [1][2]. - The senators demand that large tech companies bear the costs associated with data center construction rather than passing them on to consumers [2]. - Concerns have been raised that local regulators may yield to the financial pressure exerted by these large companies, prompting calls for federal oversight mechanisms [2]. Group 2: Economic Impact - The 5.1% year-over-year increase in electricity prices in September has contributed to persistent inflation, becoming a significant political issue [3]. - The rising electricity costs have influenced recent electoral outcomes, aiding the Democratic Party in state elections [3]. - Activists in various regions are organizing against large tax breaks for data centers, highlighting the growing local opposition to their expansion [3]. Group 3: Energy Policy - U.S. government officials are favoring natural gas and coal for energy supply while reducing subsidies for renewable energy sources [4]. - Developers are increasingly seeking to establish independent power sources to mitigate supply chain bottlenecks and regulatory challenges associated with traditional power grids [4].

Core Insights - The article discusses the challenges facing China's economy in 2025, highlighting three major issues that hinder economic recovery: the sluggish real estate market, high local government debt, and increasing household debt burdens [1][3][4]. Group 1: Real Estate Market - The real estate market, once a key driver of China's economy, has seen a significant decline, with national real estate development investment dropping nearly 10% year-on-year in 2024 and a continued decline of about 9.8% in the first half of 2025 [1][3]. - Since 2021, real estate investment has experienced approximately 10% negative growth for three consecutive years, which has reduced GDP growth by about 1.5 percentage points annually, with a total potential impact of up to 3 percentage points when considering related industries and consumer sentiment [3][4]. - The ongoing decline in housing prices, with some areas seeing drops of nearly 20% from 2021 peaks, has led to reduced consumer spending and a significant decrease in household wealth [3][4]. Group 2: Local Government Debt - Local government debt has reached over 47.5 trillion yuan, with hidden debts potentially increasing this figure significantly, primarily due to reliance on land transfer fees that have decreased by about 15% in 2024 [4][6]. - The financial strain on local governments has resulted in reduced public service spending, impacting education, healthcare, and social security, which further exacerbates the economic burden on households [6][9]. - The central government has initiated a debt relief plan of approximately 10 trillion yuan, but experts warn that this may not be sufficient to address the long-term debt issues [6][10]. Group 3: Household Debt Burden - As of early 2025, the ratio of household debt to GDP in China has reached about 60%, comparable to some developed countries, but with significantly lower per capita income levels [7][9]. - The growth rate of residents' disposable income has slowed, with nominal growth at only 5.3% in 2024, down from an average of 8.8% from 2015 to 2019, leading to increased financial strain on families [7][9]. - High costs of education and healthcare are further burdens on households, with some families spending substantial portions of their income on children's education, leading to a decline in overall living quality [9][10]. Group 4: Solutions and Outlook - A comprehensive approach is needed to address these issues, including stabilizing the real estate market, reforming local government financing, and improving household income through structural reforms [10][11]. - The central government has recognized the urgency of these problems and proposed measures such as increasing fiscal deficits and government investment to stimulate consumption [10][11]. - Despite these challenges, there are signs of resilience in the economy, with a GDP growth of 5.2% in the first quarter of 2025 and emerging sectors like AI and high-tech manufacturing showing strong growth potential [10][11].

Core Viewpoint - The A-share chain pharmacy industry is experiencing a significant adjustment period, characterized by high goodwill levels due to previous aggressive expansion strategies through mergers and acquisitions. Companies are now facing challenges in balancing scale effects with operational quality [1][2]. Goodwill Accumulation - As of the end of Q3, the total goodwill of six A-share chain pharmacy companies reached 20.778 billion yuan, with an average of 3.463 billion yuan per company. The highest goodwill was recorded by Lao Bai Xing at 5.763 billion yuan, followed by Yi Feng Pharmacy at 4.772 billion yuan and Da San Lin at 3.522 billion yuan [2]. - Goodwill as a percentage of current assets is notably high, with Lao Bai Xing at 65.28% and Jian Zhi Jia exceeding 50% at 58.7%. This trend of high goodwill has persisted for several years, with Lao Bai Xing's goodwill exceeding 5 billion yuan in 2022 [2]. Performance Trends - The performance of A-share chain pharmacies has shown divergence in the first three quarters of this year. While Shuyu Pingmin has reported a revenue increase of 5.19% to 7.446 billion yuan and turned a profit of 109 million yuan, other companies like Lao Bai Xing have seen declines in net profit by 16.11% to 529 million yuan [4]. - Despite the overall decline in net profit for some companies, Lao Bai Xing showed signs of recovery in Q3 with a slight revenue increase of 0.07% [4]. Store Count Decline - Many chain pharmacy companies are experiencing a decline in the number of stores. Lao Bai Xing reported a net decrease of 240 direct stores this year, while Yi Feng Pharmacy closed 440 stores and opened only 137 [7]. - Jian Zhi Jia also closed more stores than it opened, with a net decrease of 38 stores. In contrast, Shuyu Pingmin increased its direct store count due to acquisitions, reflecting a shift in focus from quantity to quality in store management [7]. Industry Direction - As market saturation increases, the strategy of merely expanding store numbers is becoming less effective. The future direction for chain pharmacies should focus on high-quality service and enhancing customer experience to improve competitiveness [8].

Group 1 - The China International Import Expo serves as a platform for innovation, collaboration, and education in the healthcare sector [1] - Novo Nordisk signed a strategic cooperation agreement with the Shanghai Clinical Innovation and Translation Research Institute to enhance clinical innovation and real-world research [1] - The partnership aims to leverage Shanghai's medical resources and Novo Nordisk's experience to accelerate the translation of clinical results into patient benefits [1] Group 2 - Roche China launched a public welfare initiative to create a comprehensive ecosystem for influenza prevention and treatment, involving multiple stakeholders [2] - The innovative drug, Mabalaoshuwei, demonstrated a significant reduction in household influenza infection rates from 54.45% to 6.93% [2] - The Chinese pharmaceutical retail industry is transitioning towards professionalization and digital integration, with initiatives like the "Ouying Pioneer" project [2][3] Group 3 - The integration of online and offline services in pharmaceutical retail is seen as an inevitable trend, with companies aiming to enhance accessibility to health resources [3] - Novartis emphasized the importance of both drug innovation and health education in improving patient outcomes [3]

Core Viewpoint - The A-share chain pharmacy industry is experiencing a significant adjustment period, marked by high goodwill levels due to previous aggressive expansion strategies through mergers and acquisitions. Companies are now facing declining store numbers and must balance scale effects with operational quality [2][5]. Goodwill Accumulation - As of the end of Q3, the total goodwill of six A-share chain pharmacy companies reached 20.778 billion yuan, with an average of 3.463 billion yuan per company [4]. - The company "老百姓" holds the highest goodwill at 5.763 billion yuan, followed by "益丰药房" at 4.772 billion yuan and "XD大参林" at 3.522 billion yuan [4][5]. - Goodwill as a percentage of current assets is notably high for "老百姓" at 65.28% and "健之佳" at 58.7%, indicating a heavy reliance on acquired goodwill [4]. Performance Trends - The performance of A-share chain pharmacies has shown divergence in the first three quarters of the year, with "漱玉平民" recovering from previous losses, achieving a revenue of 7.446 billion yuan, a year-on-year increase of 5.19% [7]. - "老百姓" reported a revenue decline of 1% to 16.07 billion yuan and a net profit drop of 16.11% to 529 million yuan [8]. - Other companies like "大参林" and "益丰药房" have also seen net profit growth, while "健之佳" and "一心堂" experienced declines [7][8]. Store Count Changes - Many chain pharmacy companies are witnessing a decline in store numbers, with "老百姓" reducing its direct stores by 240 this year [10]. - "益丰药房" closed 440 stores while opening only 137, resulting in a slight overall decrease in store count [10]. - In contrast, "漱玉平民" increased its direct store count due to new acquisitions, indicating a shift towards quality over quantity in store management [11]. Industry Direction - The industry is transitioning from a focus on expanding store numbers to enhancing service quality and operational efficiency, as market saturation makes previous growth strategies less effective [11].

Core Viewpoint - The A-share chain pharmacy industry is experiencing a significant adjustment period, marked by high goodwill levels and a decline in the number of direct-operated stores, necessitating a balance between scale effects and operational quality [1][4]. Goodwill Accumulation - As of the end of Q3, the total goodwill of six A-share chain pharmacy companies reached 20.778 billion yuan, with the highest being 5.763 billion yuan for Lao Bai Xing [1][3]. - Goodwill accounts for over 50% of current assets for Lao Bai Xing and Jian Zhi Jia, indicating a heavy reliance on past acquisitions for growth [1][3]. Performance Trends - The performance of the six major A-share chain pharmacies has shown divergence in the first three quarters of the year, with some companies like Shu Yu Ping Min recovering from previous losses, achieving a revenue of 7.446 billion yuan, a year-on-year increase of 5.19% [5][6]. - Lao Bai Xing reported a revenue decline of 1% to 16.07 billion yuan and a net profit drop of 16.11% to 529 million yuan in the same period, although it showed signs of recovery in Q3 [6][8]. Store Count Changes - Many chain pharmacy companies have seen a decrease in the number of stores, with Lao Bai Xing reducing its direct-operated stores by 240 to 9,981 by the end of Q3 [8][9]. - Yi Feng Pharmacy and Jian Zhi Jia also reported net decreases in store counts, reflecting a shift from quantity to quality in store management [8][9]. Industry Outlook - The industry is transitioning from a focus on rapid expansion through store count to enhancing service quality and operational efficiency, as market saturation makes previous growth strategies less effective [9].

（文章来源：每日经济新闻） 隆扬电子：每10股派1.20元人民币现金（含税），股权登记日：2025-11-11，除息除权日：2025-11-12， 数据来源《隆扬电子：关于2025年三季度权益分派实施的公告；申万一级行业：电子，非红利低波 （H30269.CSI）成分股，非红利质量（931468.CSI）成分股。 中瑞股份：每10股派发现金红利1.35元（含税），股权登记日：2025-11-11，除息除权日：2025-11-12， 数据来源《中瑞股份：2025年前三季度权益分派实施公告》；申万一级行业：电力设备，非红利低波 （H30269.CSI）成分股，非红利质量（931468.CSI）成分股。 老百姓：每股现金红利0.14元（含税），股权登记日：2025-11-11，除息除权日：2025-11-12，数据来源 《老百姓：第三季度权益分派实施公告》；申万一级行业：医药生物，非红利低波（H30269.CSI）成 分股，非红利质量（931468.CSI）成分股。 ...

Core Insights - The increase in personal savings in China, from 70 trillion to 161 trillion over five years, indicates a lack of consumer spending despite higher cash reserves [1] - The decline in real estate prices has led to decreased consumer confidence and spending, as families feel the need to retain cash for emergencies [3] - The real estate sector, once a key driver of economic growth, is now facing significant challenges, impacting related industries such as steel and home furnishings [3][5] Group 1: Economic Trends - The shift from real estate as an economic driver to a focus on technology innovation and domestic demand is highlighted in the government's "14th Five-Year Plan" [5] - The population dividend is diminishing, global trade is facing obstacles, and the land finance model is becoming unsustainable, necessitating a new economic approach [5] - The government is investing heavily in technology, with 1 trillion yuan allocated annually to support innovation, aiming to establish technology as the new economic engine [5] Group 2: Consumer Behavior - Despite increased savings, consumers are hesitant to spend due to economic uncertainty and declining property values, leading to a slowdown in retail and service sectors [1][3] - The younger generation is particularly cautious, with many recent graduates struggling to find stable employment and feeling financially insecure [3] - The government is implementing measures to alleviate consumer concerns, such as subsidies for upgrading appliances and improving social security systems [7] Group 3: Industry Opportunities - The healthcare and elderly care sectors are identified as significant growth areas, driven by the aging population and increasing demand for services [7] - The tourism industry is also experiencing growth, with consumers willing to spend on travel and experiences [7] - The emphasis on technology and innovation is creating new job opportunities in fields such as AI, nursing, and skilled trades, which are accessible to ordinary individuals [8]